Oral antiplatelet therapy in acute coronary syndromes:  What do current guidelines say?

Aydoğdu, Sinan

Journal Metrics

Impact Factor (2022): 0.8
CiteScore (2022): 1.2
Source Normalized Impact
per Paper: 0.22
SCImago Journal Rank: 0.348

52/3Current Issue Ahead of Print Archive Most Accessed Articles

Quick Search

In authors and

In titles and abstracts

In keywords

In all

pdf

Oral antiplatelet therapy in acute coronary syndromes: What do current guidelines say? [Turk Kardiyol Dern Ars]

Turk Kardiyol Dern Ars. 2015; 43(2): 13-19

Oral antiplatelet therapy in acute coronary syndromes: What do current guidelines say?

Sinan Aydoğdu
Turkey High Specialization Hospital, Cardiology, Ankara, Turkey

Oral antiplatelet therapy has a pivotal role in the treatment of acute coronary syndromes (ACS). Recent advances in the field of oral antiplatelet agents have led to guideline updates and changed the clinical practice of treating patients with ACS. This review summarizes the up-to-date recommendations of current guidelines regarding the use of oral antiplatelet agents in the setting of ACS.

Keywords: acute coronary syndrome, Oral antiplatelet therapy

How to cite this article
Sinan Aydoğdu. Oral antiplatelet therapy in acute coronary syndromes: What do current guidelines say?. Turk Kardiyol Dern Ars. 2015; 43(2): 13-19

Corresponding Author: Sinan Aydoğdu, Türkiye
Manuscript Language: Turkish

TOOLS Full Text PDF Print Download citation RIS EndNote BibTex Medlars Procite Reference Manager Share with email Share Send email to author Similar articles PubMed Google Scholar